Edition:
United States

Clementia Pharmaceuticals Inc (CMTA.OQ)

CMTA.OQ on NASDAQ Stock Exchange Global Select Market

16.68USD
3:59pm EST
Change (% chg)

$0.11 (+0.66%)
Prev Close
$16.57
Open
$16.70
Day's High
$17.00
Day's Low
$16.55
Volume
11,173
Avg. Vol
17,883
52-wk High
$18.95
52-wk Low
$15.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.314
Jun '17 0.00 -0.786
Mar '17 0.00 -1.393
FY 2016 Dec '16
Sep '16 0.00 -0.055
Jun '16 0.00 -0.049
Mar '16 0.00 -0.204
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.00 0.00 0.00 --
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 4 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 3 -0.29 -0.27 -0.33 --
Quarter Ending Mar-18 1 -0.36 -0.36 -0.36 --
Year Ending Dec-17 3 -7.16 -5.84 -8.12 --
Year Ending Dec-18 4 -1.29 -1.05 -1.57 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. -- 277.36 45.22
P/E Low - Last 5 Yrs. -- 92.80 24.21
Beta -- 0.82 0.91
Price to Sales (TTM) -- 117.72 5.89
Price to Book (MRQ) 3.22 21.83 5.66
Price to Tangible Book (MRQ) 3.26 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 70.41 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago -- 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -2,297.14 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 12.71 5.70 3.57
LT Debt to Equity (MRQ) 0.00 14.63 13.37
Total Debt to Equity (MRQ) 0.00 17.10 19.35
Interest Coverage (TTM) -- -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -219.33 15.51
Operating Margin (TTM) -- -637.28 6.68
Operating Margin - 5 Yr. Avg. -- -236.27 10.99
Pre-Tax Margin (TTM) -- -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -- -236.41 11.40
Net Profit Margin (TTM) -- -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -- -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,870,754 851,754,569
Net Income/Employee (TTM) -6,335,021 -1,731,043 99,535,212
Receivable Turnover (TTM) -- 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) -- 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -9.33 11.32
Return on Assets - 5 Yr. Avg. -- 0.11 12.28
Return on Investment (TTM) -- -11.61 14.44
Return on Investment - 5 Yr. Avg. -- 3.32 16.08
Return on Equity (TTM) -- -35.87 16.05
Return on Equity - 5 Yr. Avg. -- 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 24.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Clementia Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.78 -5.40 41 95
13 Week 1.72 -4.56 58 74
26 Week -- -- -- 58
52 Week -- -- -- 61
YTD -- -- -- 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.83%
# of Holders: 51
Total Shares Held: 21,020,984
3 Mo. Net Change: 21,000,130
# New Positions: 50
# Closed Positions: 0
# Increased Positions: 50
# Reduced Positions: 0
# Net Buyers: 50
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.